Scientific publications remain the principal way that biopharmaceutical organizations relay critical clinical trial data to key external stakeholders such as physicians and payers. Data from different phases of drug development are the earliest ways these stakeholders learn about new products and the information serves as the building blocks for how a new product is positioned in the marketplace.
Global scientific publication groups face increasing pressure for improved transparency and data disclosure. Consequently, global publications leaders find themselves in a balancing act—ensuring both scientific credibility and commercial viability. This study investigates the core aspects of the scientific publication function: structure, strategy, delivery, effectiveness, and resources.
This study provides benchmarks around the structure and leadership of publication groups; publication strategy creation and data delivery; publication channel utilization across product lifecycle; publication effectiveness and transparency; and publication staffing and budget.